UnitedHealth Group (NYSE:UNH) receives new price target of $577.00 at Morgan Stanley
UnitedHealth Group (NYSE: UNH – Get a rating) had its price target raised by Morgan Stanley research analysts from $570.00 to $577.00 in a research note released on Monday, Benzinga reports. The company currently has an “overweight” rating on shares of the healthcare conglomerate. Morgan Stanley’s price target would point to a potential upside of 8.19% from the company’s previous close.
A number of other research companies have also published reports on UNH recently. Deutsche Bank Aktiengesellschaft raised its price target on UnitedHealth Group from $482.00 to $549.00 and gave the company a “buy” rating in a research report on Monday. Mizuho raised its price target on UnitedHealth Group from $500.00 to $550.00 and gave the company a “buy” rating in a Monday, Dec. 20 research report. StockNews.com supposed coverage on UnitedHealth Group in a research report Thursday, March 31. They issued a “Strong Buy” rating for the company. Royal Bank of Canada raised its price target on UnitedHealth Group from $563.00 to $588.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, Oppenheimer raised his target price on UnitedHealth Group from $550.00 to $600.00 in a research report on Monday. Two analysts rated the stock with a hold rating, twenty-one gave a buy rating and two gave the company a strong buy rating. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $531.30.
UnitedHealth Group Shares opened at $533.30 on Monday. The company has a market capitalization of $501.78 billion, a P/E ratio of 29.19, a PEG ratio of 1.67 and a beta of 0.88. The stock has a fifty-day moving average price of $498.51 and a 200-day moving average price of $472.50. UnitedHealth Group has a 52-week low of $383.12 and a 52-week high of $553.29. The company has a current ratio of 0.78, a quick ratio of 0.79 and a debt ratio of 0.54.
UnitedHealth Group (NYSE: UNH – Get a rating) last released its quarterly results on Thursday, April 14. The healthcare conglomerate reported earnings per share (EPS) of $5.49 for the quarter, beating the Zacks consensus estimate of $5.38 by $0.11. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The company posted revenue of $80.15 billion in the quarter, versus a consensus estimate of $78.77 billion. In the same quarter a year earlier, the company had earned earnings per share of $5.31. The company’s quarterly revenue increased by 14.2% compared to the same quarter last year. As a group, stock analysts predict UnitedHealth Group will post EPS of 21.66 for the current year.
In other news, manager Richard T. Burke sold 5,000 shares in a trade that took place on Thursday, January 20. The stock was sold at an average price of $469.41, for a total transaction of $2,347,050.00. The sale was disclosed in a legal filing with the SEC, accessible via this hyperlink. Additionally, director Paul R. Garcia purchased 2,146 shares of the company in a transaction dated Tuesday, February 22. The shares were purchased at an average price of $464.97 per share, for a total transaction of $997,825.62. Disclosure of this purchase can be found here. Insiders sold 23,000 shares of the company worth $11,123,890 in the past 90 days. 0.55% of the shares are currently held by insiders.
Hedge funds have recently changed their stock holdings. Outfitter Financial LLC bought a new position in UnitedHealth Group in Q4 for a value of approximately $25,000. Blue Bell Private Wealth Management LLC bought a new position in UnitedHealth Group during the 4th quarter at a value of $29,000. Advocacy Wealth Management Services LLC increased its stake in UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate valued at $30,000 after buying 25 more shares last quarter. Cascade Investment Advisors Inc. increased its stake in UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate worth $31,000 after buying 30 more shares in the last quarter. Finally, Tortoise Investment Management LLC increased its stake in UnitedHealth Group by 54.8% during the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate worth $33,000 after buying 23 more shares in the last quarter. 86.07% of the shares are held by institutional investors and hedge funds.
About UnitedHealth Group (Get a rating)
UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment offers consumer-focused health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; coverage of health care and well-being services for people aged 50 and over to meet their needs for preventive and acute health care services, as well as services dealing with chronic diseases and other specialized problems for people elderly; Medicaid plans, health insurance and children’s health care programs; health and dental benefits; and hospital and clinical services.
Get news and reviews for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for UnitedHealth Group and related companies with MarketBeat.com’s free daily email newsletter.